We only have this paper's title and publication details.
Read it at the sourceThis analysis reveals how DON inhibits FGAMS, a key enzyme in purine biosynthesis, suggesting implications for tumor cell resilience.
DON inhibits FGAMS, a de novo purine biosynthesis enzyme, with the lowest Ki.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: